These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 36159010)

  • 1. Exosomal glypican-1 is elevated in pancreatic cancer precursors and can signal genetic predisposition in the absence of endoscopic ultrasound abnormalities.
    Moutinho-Ribeiro P; Batista IA; Quintas ST; Adem B; Silva M; Morais R; Peixoto A; Coelho R; Costa-Moreira P; Medas R; Lopes S; Vilas-Boas F; Baptista M; Dias-Silva D; Esteves AL; Martins F; Lopes J; Barroca H; Carneiro F; Macedo G; Melo SA
    World J Gastroenterol; 2022 Aug; 28(31):4310-4327. PubMed ID: 36159010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomal glypican-1 discriminates pancreatic ductal adenocarcinoma from chronic pancreatitis.
    Moutinho-Ribeiro P; Adem B; Batista I; Silva M; Silva S; Ruivo CF; Morais R; Peixoto A; Coelho R; Costa-Moreira P; Lopes S; Vilas-Boas F; Durães C; Lopes J; Barroca H; Carneiro F; Melo SA; Macedo G
    Dig Liver Dis; 2022 Jul; 54(7):871-877. PubMed ID: 34840127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glypican-1 is enriched in circulating-exosomes in pancreatic cancer and correlates with tumor burden.
    Frampton AE; Prado MM; López-Jiménez E; Fajardo-Puerta AB; Jawad ZAR; Lawton P; Giovannetti E; Habib NA; Castellano L; Stebbing J; Krell J; Jiao LR
    Oncotarget; 2018 Apr; 9(27):19006-19013. PubMed ID: 29721179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High levels of serum glypican-1 indicate poor prognosis in pancreatic ductal adenocarcinoma.
    Zhou CY; Dong YP; Sun X; Sui X; Zhu H; Zhao YQ; Zhang YY; Mason C; Zhu Q; Han SX
    Cancer Med; 2018 Nov; 7(11):5525-5533. PubMed ID: 30358133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A microRNA signature in circulating exosomes is superior to exosomal glypican-1 levels for diagnosing pancreatic cancer.
    Lai X; Wang M; McElyea SD; Sherman S; House M; Korc M
    Cancer Lett; 2017 May; 393():86-93. PubMed ID: 28232049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated glypican-1 expression is associated with an unfavorable prognosis in pancreatic ductal adenocarcinoma.
    Lu H; Niu F; Liu F; Gao J; Sun Y; Zhao X
    Cancer Med; 2017 Jun; 6(6):1181-1191. PubMed ID: 28440066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer.
    Melo SA; Luecke LB; Kahlert C; Fernandez AF; Gammon ST; Kaye J; LeBleu VS; Mittendorf EA; Weitz J; Rahbari N; Reissfelder C; Pilarsky C; Fraga MF; Piwnica-Worms D; Kalluri R
    Nature; 2015 Jul; 523(7559):177-82. PubMed ID: 26106858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of endoscopic ultrasound-guided fine needle aspiration in pretest prediction and diagnosis of pancreatic ductal adenocarcinoma].
    Wu L; Guo W; Li Y; Cheng T; Yao Y; Zhang Y; Liu B; Zhong M; Li S; Deng X; Zhu W
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1171-1178. PubMed ID: 30377133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EUS-based Pancreatic Cancer Surveillance in
    Katona BW; Long JM; Ahmad NA; Attalla S; Bradbury AR; Carpenter EL; Clark DF; Constantino G; Das KK; Domchek SM; Dudzik C; Ebrahimzadeh J; Ginsberg GG; Heiman J; Kochman ML; Maxwell KN; McKenna DB; Powers J; Shah PD; Wangensteen KJ; Rustgi AK
    Cancer Prev Res (Phila); 2021 Nov; 14(11):1033-1040. PubMed ID: 34341011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage inhibitory cytokine-1/growth differentiation factor-15 in premalignant and neoplastic tumours in a high-risk pancreatic cancer cohort.
    O'Neill RS; Emmanuel S; Williams D; Stoita A
    World J Gastroenterol; 2020 Apr; 26(14):1660-1673. PubMed ID: 32327914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single fiber reflectance spectroscopy for pancreatic cancer detection during endoscopic ultrasound guided fine needle biopsy: a prospective cohort study.
    van Manen L; Schmidt I; Inderson A; Houvast RD; Boonstra JJ; Dijkstra J; van Hooft JE; Nagengast WB; Robinson DJ; Vahrmeijer AL; Mieog JSD
    Int J Med Sci; 2022; 19(2):205-212. PubMed ID: 35165506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Key endoscopic ultrasound features of pancreatic ductal adenocarcinoma smaller than 20 mm.
    Aso A; Ihara E; Osoegawa T; Nakamura K; Itaba S; Igarashi H; Ito T; Aishima S; Oda Y; Tanaka M; Takayanagi R
    Scand J Gastroenterol; 2014 Mar; 49(3):332-8. PubMed ID: 24417737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD63-GPC1-Positive Exosomes Coupled with CA19-9 Offer Good Diagnostic Potential for Resectable Pancreatic Ductal Adenocarcinoma.
    Buscail E; Chauvet A; Quincy P; Degrandi O; Buscail C; Lamrissi I; Moranvillier I; Caumont C; Verdon S; Brisson A; Marty M; Chiche L; Laurent C; Vendrely V; Moreau-Gaudry F; Bedel A; Dabernat S
    Transl Oncol; 2019 Nov; 12(11):1395-1403. PubMed ID: 31400579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors of Endoscopic Ultrasound-Guided Tissue Acquisition for Successful Next-Generation Sequencing in Pancreatic Ductal Adenocarcinoma.
    Park JK; Lee JH; Noh DH; Park JK; Lee KT; Lee JK; Lee KH; Jang KT; Cho J
    Gut Liver; 2020 May; 14(3):387-394. PubMed ID: 31581388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) contributes to a triple-negative test in preoperative screening of pancreatic cysts.
    Wu RI; Yoon WJ; Brugge WR; Mino-Kenudson M; Pitman MB
    Cancer Cytopathol; 2014 Jun; 122(6):412-9. PubMed ID: 24327575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic ultrasound-guided injectable therapy for pancreatic cancer: A systematic review.
    Kaur J; Jaruvongvanich V; Chandrasekhara V
    World J Gastroenterol; 2022 Jun; 28(21):2383-2395. PubMed ID: 35800184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative contrast-enhanced endoscopic ultrasound in pancreatic ductal adenocarcinoma and pancreatic neuroendocrine tumors: can we predict survival using perfusion parameters? A pilot study.
    Constantin AL; Cazacu I; Burtea DE; Cherciu Harbiyeli I; Bejinariu N; Popescu C; Serbanescu M; Tabacelia D; Copaescu C; Bhutani M; Stroescu C; Saftoiu A
    Med Ultrason; 2022 Dec; 24(4):393-398. PubMed ID: 36047426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic yield of endoscopic ultrasound with fine-needle aspiration in pancreatic cystic lesions.
    Argüello L; Sánchez-Montes C; Mansilla-Vivar R; Artés J; Prieto M; Alonso-Lázaro N; Satorres-Paniagua C; Pons-Beltrán V
    Gastroenterol Hepatol; 2020 Jan; 43(1):1-8. PubMed ID: 31753518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Maspin, CK17 and Ki-67 Immunophenotyping in Diagnosing of Pancreatic Ductal Adenocarcinoma in Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytology.
    Mamdouh MM; Okasha H; Shaaban HAM; Hafez NH; El-Gemeie EH
    Asian Pac J Cancer Prev; 2021 Oct; 22(10):3299-3307. PubMed ID: 34711007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analyzing S100A6 expression in endoscopic ultrasonography-guided fine-needle aspiration specimens: a promising diagnostic method of pancreatic cancer.
    Zihao G; Jie Z; Yan L; Jing Z; Jing C; Xue L; Jing Z; Heng LW; Ru G; Jianyu H
    J Clin Gastroenterol; 2013 Jan; 47(1):69-75. PubMed ID: 22914344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.